CLINICAL PROFILE, MICROBIAL SPECTRUM, AND EARLY OUTCOMES IN SEPTIC SHOCK: A PROSPECTIVE OBSERVATIONAL STUDY FROM A TERTIARY CARE EMERGENCY DEPARTMENT

Main Article Content

Dr. Judith Mattakkal Jose
Dr. Aabid Hussain Dar
Dr. Mohammad Manzar Baig

Keywords

Septic shock, Emergency department, SOFA score, qSOFA score, Microbial profile, Antibiotic therapy, Patient outcomes

Abstract

Background: Septic shock remains a major contributor to emergency department (ED) mortality. Timely recognition and management are crucial to improving patient outcomes. This study aimed to assess the clinical profile, microbiological spectrum, treatment strategies, and outcomes of patients presenting with septic shock in a tertiary care ED. Methods: A prospective observational study was carried out over a one-year period in the Emergency Department of Government Medical College (GMC), Srinagar. A total of 102 adult patients diagnosed with septic shock and meeting the predefined inclusion criteria were enrolled. Comprehensive clinical and microbiological data were systematically recorded. Severity of illness was assessed using SOFA and qSOFA scores, and patient outcomes were monitored over a 72-hour follow-up period. Results: Among the 102 patients, the most affected age group was 61–70 years (31.4%), with a slight male predominance (55.9%). Fever (67.6%) and cough (54.9%) were the most common presenting symptoms. Respiratory infections were the leading cause (52%), followed by urinary tract infections (38.2%). Comorbidities included diabetes mellitus (44.4% mortality, p = 0.001) and hypertension (16.7% mortality, p = 0.006). Gram-negative organisms were isolated in 81.8% of cases, with Acinetobacter identified in 27.3%. Meropenem was the most frequently used antibiotic (43.1%). The overall mortality rate was 25.5%. Non-survivors had a significantly higher mean SOFA score on admission (12.6 vs. 9.5; p < 0.001). qSOFA score showed no statistically significant correlation with mortality (p = 0.115). Conclusion:
Septic shock in the ED is associated with substantial mortality, particularly in older adults with comorbidities. Early administration of broad-spectrum antibiotics and SOFA-based risk stratification remain critical to improving clinical outcomes.

Abstract 69 | Pdf Downloads 18

References

1. Chatterjee S, Bhattacharya M, Todi SK. Epidemiology of adult-population sepsis in India: a single center 5 year experience. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2017 Sep;21(9):573.
2. Liang SY, Kumar A. Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr Infect Dis Rep. 2015 Jul;17(7):493. doi: 10.1007/s11908-015-0493-6. PMID: 26031965; PMCID: PMC4581522.
3. De Waele JJ. Importance of timely and adequate source control in sepsis and septic shock. Journal of Intensive Medicine. 2024 Jul 25;4(03):281-6.
4. Paary T T, Kalaiselvan M S, Renuka M K, Arunkumar A S. Clinical profile and outcome of patients with severe sepsis treated in an intensive care unit in India The Ceylon Medical Journal. 2016 Dec;61(4):181-184. DOI: 10.4038/cmj.v61i4.8386. PMID: 28078833.
5. Todi S, Mehta Y, Zirpe K, et al., SEPSIS Registry. A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) study. Crit Care. 2024 Nov 19;28(1):375. doi: 10.1186/s13054-024-05176-8. PMID: 39563464; PMCID: PMC11577944.
6. The Seventieth World Health Assembly. Improving the prevention, diagnosis and clinical management of sepsis.29 May 2017. Availableat:http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R7-en.pdf. Last accessed March 5th, 2018.
7. Liu, V.; Escobar, G.J.; Greene, J.D.; Soule, J.; Whippy, A.; Angus, D.C.; Iwashyna, T.J. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014, 312, 90–92
8. Shankar-Hari, M.; Harrison, D.A.; Rowan, K.M. Differences in Impact of Definitional Elements on Mortality Precludes International Comparisons of Sepsis Epidemiology—A Cohort Study Illustrating the Need for Standardized Reporting. Crit. Care Med. 2016, 44, 2223–2230.
9. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, et al. (1997) Epidemiology of sepsis syndrome in eight academic medical centers. JAMA 279: 234-240.
10. Anderson RN, Smith BL. Deaths: Leading causes for 2001. Natl Vital Stat Rep 2003;52(9): 1-86.
11. Tosi S, Chatterjee S, Sahu S, Bhattacharyya M. Epidemiology of severe sepsis in India: an update. Critical Care 2010; 14: P382.
12. Balaji MV. A study on the incidence of adrenal insufficiency in patients with septic shock. Dissertation Submitted to Tamil Nadu Dr.M.G.R Medical University, 2019.
13. Chatterjee S, Chattopadhyay A and Todi SK. Outcomes of severe sepsis among adults in a tertiary care hospital in Kolkata – A preliminary study. J Anest and Inten Care Med 2018; 6(2): JAICM.MS.ID.555684 (2018)
14. Hammond NE, Kumar A, Kaur P, Vijayaraghavan BKT, Ghosh A, Grattan S et al. Estimates of sepsis prevalence and outcomes in adult patients in the ICU in India: a cross-sectional study. CHEST 2022; https://doi.org/10.1016/ j.chest.2021.12.673.
15. Babu M, Menon VP, Uma DP. Epidemiology and outcome among severe sepsis and septic shock patients in a South Indian tertiary care hospital. Int J Pharm Pharm Sci 2017;9(5):256-259.
16. Abhinandan KS and Vedavathi R. Usefulness of sequential organ failure assessment (sofa) and acute physiology and chronic health evaluation II) score in analysing patients with multiple organ dysfunction syndrome in sepsis. Journal of Evolution of Medical and Dental Sciences 2013;2(49):9591- 05
17. Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290(19):2588–98
18. Choudhury G, Mandal P, Singanayagam A et al. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis. Clin Microbiol Infect 2011; 17(12): 1852–58.
19. Singer M, Deutschman CS, Seymour CW et al. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315(8): 801–10
20. Bai X, Yu W, Ji W, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18 (5):532
21. De Backer D, Aldecoa C, Njimi H, Vincent J-L. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40(3):725–730
22. Tian H, Zhou J, Weng L, Hu X, Peng J, Wang C et al. Accuracy of qSOFA for the diagnosis of sepsis-3: a secondary analysis of a population-based cohort study. J Thorac Dis 2019;11(5):2034-42.

Most read articles by the same author(s)